HemOnc Today

CURRENTLY VIEWING:

The following articles appeared in the print edition of HEMONC TODAY.

Table of Contents
Cover Story

Increased endometrial cancer incidence prompts calls for more screening, research funding

Point/Counter

Does increased endometrial cancer incidence warrant more intensive screening?

Meeting News

Bevacizumab plus chemotherapy prolongs PFS for recurrent ovarian cancer

Editorial

Cancer clinical trials: Not suitable for prime time

John Sweetenham, MD

Meeting News

Collaborative investment may expedite drug development for pediatric cancer

Commentary

Bidirectional immuno-oncology educational program benefits community practices

Meeting News

Black men achieve deeper response to abiraterone acetate for advanced prostate cancer

Adjuvant FOLFIRINOX new standard of care for pancreatic cancer

Adjuvant docetaxel shows benefit for gastric cancer

Novel nivolumab combination shows efficacy for advanced solid tumors

Benefit of first-line alectinib persists over crizotinib for ALK-positive lung cancer

First-line atezolizumab improves PFS for advanced squamous non-small cell lung cancer

Geriatric assessment improves oncologists’ communication with older patients

CAR T-cell therapy bb2121 shows sustained promise for multiple myeloma

CAR T-cell therapy benefit for pediatric leukemia dependent on prompt treatment

Ibrutinib plus rituximab improves PFS in Waldenström’s macroglobulinemia

Nelarabine shows ‘best ever survival data’ for children, young adults with T-cell ALL

Long-term treatment-free remission achievable for chronic myeloid leukemia

Targeted inhibitor induces responses for soft tissue sarcoma

Cognitive behavioral therapy, acupuncture reduce insomnia among cancer survivors

FDA commissioner: Greater efficiencies can unlock opportunities created by better science

Cytoreductive nephrectomy no longer the standard for metastatic renal cell carcinoma

Germline variant alleles may predict response to first-line abiraterone for metastatic prostate cancer

Neoadjuvant pembrolizumab induces pathologic response in bladder cancer

PET response after induction chemotherapy may predict esophageal cancer outcomes

In the Journals Plus

Cancer increases risk for subsequent diabetes

US cancer deaths continue to decline

Multigene sequencing replaces BRCA testing after breast cancer diagnosis

Mortality risk greater for male transfusion recipients with previously pregnant donor

Higher vitamin D levels associated with lower colorectal cancer risk for women

FDA News

FDA grants fast track designation to fimepinostat for lymphoma subtype

FDA approves Fulphila, first Neulasta biosimilar, to prevent infection during cancer treatment

FDA grants priority review to Hemlibra for hemophilia A without factor VIII inhibitors

FDA grants priority review to larotrectinib for certain solid tumors

FDA grants priority review to Promacta for frontline treatment of severe aplastic anemia

FDA breakthrough therapy designation not associated with improved safety, efficacy

11 institutions join AACR Project GENIE Consortium

Radiation oncologist to serve as American Radium Society’s president-elect